Karnataka Bank. Rating: BUY. Bank - Private. Short Note. Brief Financials

Transcription

1 Karnataka Bank Bank - Private Date June 11, 2018 CMP (Rs.) 120 Target (Rs.) 163 Potential Upside 37% BSE Sensex NSE Nifty Scrip Code Bloomberg KBLIN Reuters KBNK.BO BSE Group A BSE Code NSE Symbol KTKBANK Market Data Market Cap Equity Sh. Cap. (Rs) Cr) Wk High/Low (Rs.) 179 / 107 Quarterly Avg Volume Face Value (Rs.) 10 Shareholding Pattern Short te Rating: BUY Incorporated in 1924, Karnataka Bank Limited (KBL) is one of the oldest private sector banks. It offers wide variety of products and services to around 9.7 million customers. KBL has bouquet of products in corporate and retail banking like housing loans, mortgages, vehicle loans, gold loans, educational loans etc. It has built network of 2,176 service outlets with 800 branches, 2 extension counters and 1,374 ATMs across India. KBL s Q4 FY18 performance was characterized by a better pre provisioning profit of Rs. 475 crores (44% y- o-y growth) on improving the net interest revenue traction which grew by 54% y-o-y to Rs. 541 crores and controlled operating expenses (Q4 FY18 cost to income ratio 43.14% as compared to 50.4% a year ago). As on FY18, total business of the bank (advances and deposits) is Rs. 1, 10,123 crores. Strong loan growth and borrower profile: Focus on retail and corporate sectors led to 28% loan growth in FY18 which was one of the challenging areas for the bank in the last couple of years. Corporate advances constitute 55% of total loan portfolio with balance in retail. Corporate borrowers with AAA and AA ratings constitute 13% and 8% respectively of the total gross advances. Going forward, management will focus on MSME, mid corporate and retail loans. Improved NIM and controlled operating expenses support operating profitability in FY18: NIM which improved by 39 bps y-o-y to 3.18% was mainly driven by the robust growth in NII (25% y-o-y to Rs crores). Owing to the miniscule increase in operating expenditures of only 3% y-o-y, cost-to-income (C/I) ratio reduced to 48% in FY18 v/s 57% in FY17. As a result, pre provisioning profit for FY18 was up by 48% to Rs crores (FY17: Rs. 995 crores).management has given guidance of NIM more than 3% in FY19. Asset Quality to stabilize: Asset quality of the bank has deteriorated sharply over the past years with GNPA increasing from 2.92% in FY14 to 4.91% in FY18. Fresh accretion to NPA was Rs. 654 crores as on FY18. Three power accounts have been identified under NPA and adequate provision for the same was made. Under NCLT cases, the bank had four accounts of Rs 317 crores and all these accounts were treated as NPA. Management commented that the bank has taken entire NPA stress in Q4 FY18 and expects slippages to minimize going forward with more focus on betterrated corporate and improving recovery management. Comparative Price Chart Marginal decline in CASA: CASA share has gone marginally down to 28% in FY18 v/s 29% in FY17. Retail term deposits were 71% of total deposits. With management focus on increasing the retail book, we expect CASA to improve going forward. Going forward, management aims to maintain CASA share of at least 30%. Expanding Reach: Over the last five years, the pace of branch additions of KBL has increased sharply from 600 in FY14 to 800 in FY18. The number of ATMs has almost been doubled from 700 in FY14 to 1374 in FY18. Bank is expanding its reach in northern region from 19 branches in FY14 to 24 branches in FY18. Management commented that Bank is planning to open 35 new branches in FY19 taking the total number of branches to 835. Arun Gopalan Research Analyst arungopalan@systematixgroup.in Brief Financials Outlook and Valuation: We are positive on KBL s business outlook on the back of following factors including 1) high likelihood of strong credit growth, 2) enhanced focus on retail, SME and mid corporate clients, 3) improving asset quality outlook and 4) improving operating efficiencies. Therefore, we recommend BUY recommendation on the stock with a target price of Rs. 163 based on 0.7x FY20E adjusted book value, an upside of 37%. Financials NII PPP PAT EPS (Rs) FY FY FY19E FY20E ABVPS (Rs.) P/ABV (x) GNPA NNPA NIM CAR

2 Advances and Growth in Advances CASA and CASA Ratio NII and NIM% Ratios Gross NPA and Gross NPA % Net NPA and Net NPA %

3 QUARTERLY FINANCIALS Healthy Net Interest Income traction, supported by improving advances growth and sustained margins Controlled expenses resulted into lower operating expenses Income Statement (Rs. in crores) Interest Income Interest Expense Net Interest Income n-interest Income Net Revenue Employees Expenses Other Operating Expenses Profit Before Provisions Provisions Profit Before tax Tax Net Profit EPS (Rs.) Asset Quality Gross NPA (Rs in crores) Gross NPA Net NPA (Rs in crores) Net NPA Interesting part: NIM of Q4 FY18 is more than FY18 Financial Ratios Net Interest Margin (NIM) Yield on Advances Cost of Deposits RoA RoE CRAR CASA

4 YEARLY FINANCIALS Income Statement (Rs. in crores) Interest Income Interest Expense Net Interest Income n-interest Income Net Revenue Employees Expenses Other Operating Expenses Profit Before Provisions Provisions Profit Before Tax Tax Net Profit EPS (Rs.) DPS (Rs.) Balance sheet (Rs. in crores) Capital Reserves and Surplus Borrowings Other Liabilities and Provisions Total Liabilities Advances Investments Fixed Assets Other Assets Total Assets Key Assumptions and Ratios Growth ratios Advances Net Interest Income Profit After Tax Margin ratios Net Interest Margin (NIM) Yield of Funds Cost of Funds Valuation ratios Book Value per Share (Rs.) Adjusted Book Value per Share (Rs.) P/ BV P/ ABV Return ratios RoA RoE Other ratios Cost to Income Ratio CRAR Gross NPA Net NPA

5 DISCLOSURES/ APPENDIX I. ANALYST CERTIFICATION I, Arun Gopalan, hereby certify (1) that the views expressed in this research report accurately reflect my personal views about any or all o f the subject securities or issuers referred to in this research report, (2) part of my compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in this research report by Systematix Shares and Stocks (India) Limited or its Group/associates companies. (3) has taken reasonable care to achieve and maintain independence and objectivity in making any recommendations. Disclosure of Interest Statement Response Analyst holding in the stock Served as an officer, director or employee II. ISSUER SPECIFIC REGULATORY DISCLOSURES, UNLESS SPECIFICALLY MENTIONED IN POINT NO. 9 BELOW: 1. The Research Analyst(s), Systematix Shares and Stocks (India) Limited, Associate of Analyst or his relative does not have any financial interest in the company(ies) covered in this report. 2. The Research Analyst, Systematix Shares and Stocks (India) Limited or its associates or relatives of the Research Analyst affiliates collectively do not hold more than 1% of the securities of the company (ies) covered in this report as of the end of the month immediately preceding the distribution of the research report. 3. The Research Analyst, his associate, his relative and Systematix Shares and Stocks (India) Limited do not have any other material conflict of interest at the time of publication of this research report. 4. The Research Analyst, Systematix Shares and Stocks (India) Limited and its associates have not received compensation for investment banking or merchant banking or brokerage services or for any other products or services from the company(ies) covered in this report, in the past twelve months. 5. The Research Analyst, Systematix Shares and Stocks (India) Limited or its associates have not managed or co-managed in the previous twelve months, a private or public offering of securities for the company (ies) covered in this report. 6. Systematix Shares and Stocks (India) Limited or its associates have not received compensation or other benefits from the company(ies) covered in this report or from any third party, in connection with the research report. 7. The Research Analyst has not served as an Officer, Director or employee of the company (ies) covered in the Research report. 8. The Research Analyst and Systematix Shares and Stocks (India) Limited has not been engaged in market making activity for the company(ies) covered in the Research report. 9. Details Systematix Shares and Stocks (India) Limited, Research Analyst and its associates pertaining to the companies covered in the Research report: Sr. Particulars Yes /.. 1 Whether compensation has been received from the company(ies) covered in the Research report in the past 12 months for investment banking transaction by Systematix Shares and Stocks (India) Limited 2 Whether Research Analyst, Systematix Shares and Stocks (India) Limited or its associates or relatives of the Research Analyst affiliates collectively hold more than 1% of the company(ies) covered in the Research report 3 Whether compensation has been received by Systematix Shares and Stocks (India) Limited or its associates from the company(ies) covered in the Research report 4 Systematix Shares and Stocks (India) Limited or its affiliates have managed or co-managed in the previous twelve months a private or public offering of securities for the company(ies) covered in the Research report 5 Research Analyst, his associate, Systematix Shares and Stocks (India) Limited or its associates have received compensation for investment banking or merchant banking or brokerage services or for any other products or services from the company(ies) covered in the Research report, in the last twelve month 10. There are no material disciplinary action that been taken by any regulatory authority impacting equity research analysis activities. 11. Systematix Shares and Stocks (India) Limited is in a process of seeking registration under SEBI (Research Analyst) Regulations, EXPLANATION TO RATINGS: BUY: TP>15%; ACCUMULATE: 5%<TP<15%; HOLD: -5%<TP<5%; REDUCE: -15%<TP<-5%; SELL: TP<-15% III. DISCLAIMER The information and opinions contained herein have been compiled or arrived at, based upon information obtained in good faith from sources believed to be reliable. Such information has not been i ndependently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy completeness or correctness. This document is for information purposes only. This report is based on information that we consider reliable, but we do not represent that it is accurate or complete, and one should exercise due caution while acting on it. Descriptions of any company or companies or their securities mentioned herein are not complete and this document is not, and should not be constr ued as an offer or solicitation of an offer to buy or sell any securities or other financial instruments. Past performance is not a guide for future performance, future returns are not guaranteed and a loss of original capital may occur. All opinions, projections and estimates constitute the judgment of the author as on the date of the report and these, plus an y other information contained in the report, are subject to change without notice. Prices and availability of financial instruments also are subject to change without notice. This report is not directed to or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity that is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject to Systematix Shares and Stocks (India) Limited or its affiliates to any registration or licensing requirement within such jurisdiction. If this report is inadvertently send or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. Neither this document nor any copy of it may be taken or transmitted into the United State (to U.S.Persons), Canada, or Japan or distributed, directly or indirectly, in the United States or Canada or distributed or redistributed in Japan or to any resident thereof. Any unauthorized use, duplication, redistribution or disclosure of this report including, but not limited to, redistribution by electronic mail, posting of the report on a website or page, and/or providing to a third party a link, is prohibited by law and will result in prosecution. The information contained in the Report is intended solely for the recipient and may not be further distributed by the recipient to any third party. Systematix Shares and Stocks (India) Limited generally prohibits its analysts, persons reporting to analysts, and members of their households from maintaining a financial interest in the securities or derivatives of any companies that the analysts cover. Additionally, Systematix Shares and Stocks (India) Limited generally prohibits its analysts and persons reporting to analysts from serving as an officer, director, or advisory board me mber of any companies that the analysts cover. Our salespeople, traders, and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clie nts that reflect opinions that are contrary to the opinions expressed herein. Our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. The views expressed in this research report reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The compensation of the analyst who prepared this document is determined exclusively by Systematix Shares and Stocks (India) Limited however, compensation may relate to the revenues of the Systematix Group as a whole, of which investment banking, sales and trading are a part. Research analysts and sales persons of Systematix Shares and Stocks (India) Limited may provide important inputs to its affiliated company(ies). Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations, which could have an adverse effect on their value or price, or the income derived from them. In addition, investors in securities such as ADRs, the values of which are influenced by foreign currencies effectively assume currency risk. MUTUAL FUND INVESTMENTS ARE SUBJECT TO MARKET RISKS, READ ALL SCHEME RELATED DOCUMENTS CAREFULLY. Systematix Shares and Stocks (India) Limited, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of th is report including but not restricted to fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. Systematix Shares and Stocks (India) Limited and its affiliates, officers, directors, and employees subject to the information given in the disclosures may: (a) from time to time, have long or short positions in, and buy or sell the securities thereof, of company (ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation (financial interest) or act as a market maker in the financial instruments of the company (ies) discussed herein or act as advisor or lender / borrower to such company (ies) or have other potential material conflict of interest with respect to any recommendation and related information and opinions. The views expressed are those o f the analyst and the Company may or may not subscribe to the views expressed therein. Systematix Shares and Stocks (India) Limited, its affiliates and any third party involved in, or related to, computing or compiling the information hereby expressly disclaim all warranties of originality, accuracy, completeness, merchantability or fitness for a particular purpose with respect to any of this information. Without limiting any of the foregoing, in no event shall Systematix Shares and Stocks (India) Limited, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. The Company accepts no liability whatsoever for the actions of third parties. The Report may provide the addresses of, or contain hyperlinks to, websites. Except to the extent to which the Report refers to website material of the Company, the Company has not reviewed the linked site. Accessing such website or following such link through the report or the website of the Company shall be at your own risk and the Company shall have no liability arising out of, or in connection with, any such referenced website Systematix Shares and Stocks (India) Limited shall not be liable for any delay or any other interruption which may occur in presenting the data due to any technical glitch to present the data. In no event shall the Systematix Shares and Stocks (India) Limited be liable for any damages, including without limitation, direct or indirect, special, incidental, or consequential damages, losses or expenses arising in connection with the data pre sented by Systematix Shares and Stocks (India) Limited through this presentation. Neither Systematix Shares and Stocks (India) Limited, nor any of its other group companies or associates, shall be responsible for any decisions taken on the basis of this report. Investors are advised to consult their Investment and Tax consultants before taking any investment decisions based on this report. Systematix Shares and Stocks (India) Limited. CIN : U65993MH1995PLC BSE SEBI Reg..: INZ (Member Code: 182) NSE SEBI Reg..: INZ (Member Code: 11327) MSEI SEBI Reg..: INZ (Member Code: 17560) Depository Participant SEBI Reg..: IN-DP-CDSL (DP Id: 34600) PMS SEBI Reg..: INP Research Analyst SEBI Reg..: INH Investment Advisor SEBI Reg.. INA AMFI : ARN Registered and Corporate Office Address: The Capital, A-wing, , 6th Floor, Plot. C-70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai